Thousand Oaks, CA, United States of America

Daren Bates

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Amgen Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daren Bates. Retrieved from https://idiyas.com/inventor/daren-bates

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Daren Bates: Innovator in Antibody Treatment

Introduction

Daren Bates is a prominent inventor based in Thousand Oaks, California. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work focuses on innovative methods for treating diseases through advanced medical technologies.

Latest Patents

Daren Bates holds a patent for "Anti-PD-1 antibodies and methods of treatment." This patent includes PD-1 antigen-binding proteins and related nucleic acids, vectors, host cells, kits, and pharmaceutical compositions. The methods outlined in his patent provide new approaches for making PD-1 antigen-binding proteins and treating subjects effectively.

Career Highlights

Bates is associated with Amgen Inc., a leading biotechnology company known for its focus on innovative therapies. His role at Amgen has allowed him to contribute to groundbreaking research and development in the field of antibody treatments.

Collaborations

Daren Bates has collaborated with notable colleagues, including Khaled M K Z Ali and Neeraj Jagdish Agrawal. These partnerships have enhanced the research and development efforts in the biotechnology sector.

Conclusion

Daren Bates is a key figure in the advancement of antibody treatments, with a focus on innovative solutions for medical challenges. His contributions through patents and collaborations continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…